Quantification Assay of Diabetic Drug Sitagliptin in Pharmaceutical Preparations A Review

doi:https://doi.org/10.5281/zenodo.15778061

Biomedicine and Chemical Sciences

2025, Volume 4, Issue 2 : 59-63 doi: https://doi.org/10.5281/zenodo.15778061

Review Article

Quantification Assay of Diabetic Drug Sitagliptin in Pharmaceutical Preparations A Review

Hana Shuker Mahmood

Nada Ahmad Khalil

DOI : https://doi.org/10.5281/zenodo.15778061

Received

Jan. 10, 2025

Revised

March 20, 2025

Accepted

March 27, 2025

Published

April 1, 2025

Abstract

The diabetic drug Sitagliptin (STG) is a hypoglycemic drug of the dipeptidyl peptidase-4(DPP-4) inhibitor. The new therapeutic action by DPP-4 inhibitors depends on the decrease of the glucagon levels and stimulates glucose-dependent insulin release. This is done through inhibition of the inactivation of incretins, particularly glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP), thereby improving glycemic control. Quantification Assay of STG in pharmaceutical preparations is one of the researchers' interests because of its importance in the manufacturing of drugs, quality control of the dosage forms, and the accuracy in determining the dose. However, in biological fluids, determination of the drugs is of greater importance, as monitoring the drug, studying its pharmacokinetics, bioavailability, potency, the chemical and biological actions of the drugs and their metabolites in the body. This is a review of STG, its properties, action, and methods of determination.

Keywords

Diabetic drug sitagliptin

Pharmaceutical preparations

Quantification assay

REFERENCES

Ahmed, R. M., Hadad, G. M., El-Gendy, A. E., & Ibrahim, A. (2018). Development of HPLC method for determination of sitagliptin in human plasma using fluorescence detector by experimental design approach. Analytical Chemistry Letters, 8(6), 813-828. https://doi.org/10.1080/22297928.2018.1545603
Anderson, P. O. (2018). Treating diabetes during breastfeeding. Breastfeeding Medicine, 13(4), 237-239. https://doi.org/10.1089/bfm.2018.0036
Bhargavi, P. D., Lolla, S., Sugunan, S., Gubbiyappa, K. S., Khan, A. A., Alanazi, A. M., & Nayak, B. V. (2023). The simultaneous quantification of Sitagliptin and Irbesartan in rat plasma using the validated LC-MS/MS method is applied to a pharmacokinetic study. Journal of Chromatography B, 1221, 123677. https://doi.org/10.1016/j.jchromb.2023.123677
de Paula e Mancilha, T., de Paula, C. E. R., Cassella, R. J., & Pacheco, W. F. (2013). Direct determination of sitagliptin in pharmaceutical formulations and its determination in urine after solid‐phase extraction by spectrofluorimetry. Luminescence, 28(6), 873-878. https://doi.org/10.1002/bio.2449
Disha, N. S., & Gurupadhayya, B. M. (2015). Spectrophotometric determination of Sitagliptin phosphate in bulk and pharmaceutical formulations. International Journal of Innovative Science, Engineering and Technology, 2(7), 702-709.
El-Bagary, R. I., Elkady, E. F., & Ayoub, B. M. (2011). Spectrophotometric methods for the determination of sitagliptin and vildagliptin in bulk and dosage forms. International Journal of Biomedical Science: IJBS, 7(1), 55. https://pubmed.ncbi.nlm.nih.gov/23675221/
Hirshberg, B., & Raz, I. (2011). Impact of the US Food and Drug Administration cardiovascular assessment requirements on the development of novel antidiabetes drugs. Diabetes Care, 34(Suppl 2), S101. https://doi.org/10.2337/dc11-s202
Nirogi, R., Kandikere, V., Mudigonda, K., Komarneni, P., Aleti, R., & Boggavarapu, R. (2008). Sensitive liquid chromatography tandem mass spectrometry method for the quantification of sitagliptin, a DPP‐4 inhibitor, in human plasma using liquid–liquid extraction. Biomedical Chromatography, 22(2), 214-222. https://doi.org/10.1002/bmc.926
Patil, S., Ramesh, B., Hareesh, A. R., Patil, K., & Dhokane, A. (2010). Development and Validation of RP-HPLC Method for the Estimation of Sitagliptin Phosphate in Tablet Dosage Form. Asian Journal of Research in Chemistry, 3(3), 653-655.
Rajeswari, A., Saritha, N., & Devanna, N. (2022). Validated RP-HPLC Method Development for Estimation of Ertugliflozin and Sitagliptin in Bulk and Dosage Forms. Journal of Pharmaceutical Research International, 34, 22-26.
Ravisankar, P., Mounika, G., Devadasu, C., & DevalaRao, G. (2014). A simple validated UV Spectrophotometric method for quantitative analysis of Sitagliptin phosphate in pharmaceutical dosage form. J. Chem. Pharmaceut. Sci, 7, 254.
Raza, A., Murtaza, S. H., Hanif, S., Iqbal, J., Ali, I., Aftab, T., ... & Syed, M. A. (2022). Validation of a rapid and economical RP-HPLC method for simultaneous determination of metformin hydrochloride and sitagliptin phosphate monohydrate: Greenness evaluation using AGREE score. Pakistan Journal of Pharmaceutical Sciences, 35(1).
Sekaran, C. B., & Rani, A. P. (2010). Development and validation of spectrophotometric method for the determination of DPP-4 inhibitor, sitagliptin, in its pharmaceutical preparations. Eclética Química, 35, 45-53. https://doi.org/10.1590/S0100-46702010000300003
Shantikumar, S., Sreekanth, G., SurendraNath, K. V., JaferValli, S., & Satheeshkumar, N. (2014). Compatibility study between sitagliptin and pharmaceutical excipients used in solid dosage forms. Journal of Thermal Analysis and Calorimetry, 115, 2423-2428. https://doi.org/10.1007/s10973-013-3329-3
Singh, D., Jain, N. K., Tiwari, A., & Khan, N. (2022). Development and Validation of Simultaneous Equation Method for Estimation of Sitagliptin and Saxagliptin in Combined Pharmaceutical Dosage Form by Using UV Spectrophotometric Method. International Journal of Medical Sciences and Pharma Research, 8(2), 83-90. https://doi.org/10.22270/ijmspr.v8i2.43
Sireesha, D., & Sravya, E. (2017). Development and validation of RP-HPLC method for the estimation of sitagliptin phosphate in tablet dosage form. International Journal of Applied Pharmaceutical Sciences and Research, 2(03), 41-45. https://doi.org/10.21477/ijapsr.v2i3.8099
Sirigiri, N., Subramanian, N. S., Reddy, G., & Kumar, N. (2018). Stability indicating method development and validation for simultaneous estimation of sitagliptin phosphate and metformin HCl in tablets by HPLC. International Journal of Pharmaceutical Sciences and Research, 9(10), 4294-4302.

Recommended Articles

Original Article Open Access

A FRAMEWORK OF MONOCLONAL ANTIBODIES AND RELATED PRODUCTION ENGINEERING

Navneet Kumar Verma

2025, Volume 4, Issue 4 : 26-34

Download PDF

Research Article Open Access

Spectroscopic and Thermal Studies of Some Palladium(II) Complexes with 2-amino-4-(4-subsistuted phenyl)thiazole Derivatives

Thaaer K. Maki AL-Jaffer ,

Zeki O Naser ,

Ali Jameel Hameed

2022, Volume 1, Issue 2 : 78-82

DOI: https://doi.org/10.48112/bcs.v1i2.104

Download PDF

Research Article Open Access

The Role of Vitamin D and Zinc In Facing COVID-19 Injury

Yazi Abdullah Jassima

2022, Volume 1, Issue 1 : 6-10

DOI: https://doi.org/10.48112/bcs.v1i1.76

Download PDF

Research Article Open Access

Design and Synthesis Ligands Tetradents Substituted with Halogenes in α- Position and Conjugation with Riboflavin (Bioconjugates)

Nasser Thallaj

2022, Volume 1, Issue 2 : 47-56

DOI: https://doi.org/10.48112/bcs.v1i2.85

Download PDF

Biomedicine and Chemical Sciences journal thumbnail

Volume 4, Issue 2

Downloads

Download PDF xml

Download XML

Citations

2 Views

0 Downloads

Share this article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

Biomed. Chem. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.